Keyphrases
Systemic Sclerosis
100%
Single Center
32%
Interstitial Lung Disease
30%
Scleroderma
20%
Nailfold Capillaroscopy
20%
Forced Vital Capacity
17%
Pulmonary Arterial Hypertension
16%
Anti-PM-Scl Antibody
15%
Pulmonary Hypertension
11%
Patient Survival
11%
Anti-RNA Polymerase III Antibodies
11%
Anti-Scl70
11%
Clinical Features
11%
Respiratory Parameters
10%
Videocapillaroscopy
10%
Vasculopathy
10%
Survival Disparities
10%
Digital Ulcers
10%
Hepatobiliary
10%
Exhaled Breath Condensate pH
10%
Narrative Review
10%
Patient Characteristics
10%
Spain
10%
Lung Transplantation
10%
High Sensitivity
10%
Lung Injury
10%
Prognostic Role
10%
Fractional Exhaled Nitric Oxide (FeNO)
10%
Novel Risk Factors
10%
Early Diagnosis
10%
Pathogenic Mechanism
10%
Negative Predictive Value
10%
Dysregulation
10%
Transcriptomics
10%
Inflammatory Pathways
10%
Disease-associated
10%
CD4+ T Cells
10%
Epigenomics
10%
Susceptibility Loci
10%
Malignancy
8%
Differentially Expressed Genes
8%
Neoangiogenesis
8%
Capillary
8%
Cancer Risk
7%
Scleroderma Renal Crisis
7%
Diffuse Cutaneous SSc
7%
Exhaled Breath Condensate
6%
Exhaled Breath
6%
Pulmonary Function Test
6%
Independent Risk Factors
5%
Medicine and Dentistry
Systemic Scleroderma
75%
Interstitial Lung Disease
30%
Scleroderma
30%
Pulmonary Hypertension
20%
Forced Vital Capacity
18%
Malignant Neoplasm
11%
DNA Directed RNA Polymerase III
11%
Clinical Feature
10%
Capillary
10%
Exhaled Breath Condensate
10%
Lung Transplantation
10%
Finger Ulcer
10%
Nitric Oxide
10%
Cohort Analysis
10%
Capillaroscopy
10%
Early Diagnosis
10%
Vascular Disease
10%
DLCO
8%
Lung Function Test
7%
Diseases
7%
Carbon Monoxide
6%
Breathing
5%
Progression Free Survival
5%
Biological Marker
5%
Cancer
5%
Immunology and Microbiology
Systemic Scleroderma
80%
Scleroderma
27%
Forced Vital Capacity
20%
Monospecific Antibody
18%
RNA Polymerase
13%
Immunology
10%
Breathing
10%
T-Helper Cell
10%
Exhaled Nitric Oxide
10%
Lung Artery Pressure
10%
Transcriptomics
10%
Capillary
10%
Epigenetics
10%
Lung Function
9%
Progression Free Survival
7%
Promoter Region
5%
